Диссертация (1140198), страница 18
Текст из файла (страница 18)
– 2010. –Vol. 42, № 2. – P. 252–256.134. Randomized trial of pramipexole for patients with restless legs syndrome(RLS) and RLS-related impairment of mood / P. Montagna [et al.] // Sleep Med. – 2011.– Vol. 12, № 1. – P. 34–40.135. Restless bladder’ and the boundaries of the restless legs syndrome /E. Antelmi [et al.] // Eur. J. Neurol.
– 2013. – Vol. 20, № 11. – P. 128.136. Restless legs syndrome (RLS) and periodic limb movement disorder(PLMD): acute placebo-controlled sleep laboratory studies with clonazepam / M. Saletu[et al.] // Eur. Neuropsychopharmacol. – 2001. – Vol. 11, № 2. – P. 153–161.137. Restless legs syndrome / W. A. Hening [et al.] // Phyladelphia: SaundersElsevier. – 2009. – P. 312.138. Restless legs syndrome augmentation associated with dopamine agonist andlevodopa usage in a community sample / R. P. Allen [et al.] // Sleep Med. – 2011. – Vol.12, № 5.
– P. 431–439.139. Restless Legs Syndrome Foundation: medications [Электронныйресурс].–Режимдоступа:https://www.rls.org/treatment/medications(датаобращения31.03.2017).140. Restless legs syndrome in diabetic neuropathy: a frequent manifestation ofsmall fiber neuropathy. / F. Gemignani [et al.] // J. Peripher. Nerv. Syst. – 2007. – Vol. 12,№ 1. – P.
50–53.141. Restless legs syndrome in Parkinson’s disease / C. M. Peralta [et al.] // Mov.Disorders. – 2009. –Vol. 24, № 14. –P. 2076–2080142. Restless legs syndrome prevalence and impact: REST general population103study / R. P. Allen [et al.] // Arch. Intern. Med. – 2005. – Vol. 165, № 11. –P. 1286–1292.143. Restless legs syndrome: a clinical study of 55 patients / C. L. Bassetti [et al.]// Eur. Neurol.
– 2001. – Vol. 45, № 2. –P. 67–74.144. Restless legs syndrome: diagnostic criteria, special considerations, andepidemiology. A report from the restless legs syndrome diagnosis and epidemiologyworkshop at the National Institutes of Health. / R. P. Allen [et al.] // Sleep Med. – 2003.– Vol. 4, № 2. – P. 101–119.145. Restless legs syndrome/Willis Ekbom disease: new diagnostic criteriaaccording to different nosology // S.
Marelli [et al.] // Arch Ital Biol. – 2015. – Vol. 153,№ 2. – P. 184–193.146. Roth, A. J. Cognitive, psychomotor and polysomnographic effects oftrazodone in primary insomniacs / A. J. Roth, W. V. McCall, A. Liguori //J Sleep Res. –2011– Vol. 20, № 4. – P. 552–558.147. Sachdev, P. Akathisia and Restless Legs / P. Sachdev. – 2006. – P. 311.148.
Sandyk, R. The opioid system in the restless legs and nocturnal myoclonussyndromes / R. Sundyk, M. A. Gilman // Sleep. – 1986. – Vol. 9. – P. 370–371.149. Salas, R. E. Update in restless legs syndrome / R. E. Salas, C. E. Gamaldo,R. P. Allen. // Curr Opin Neurol. –2010. – Vol. 23, №4. – P. 401–406.150. Schlesinger, I.
Restless legs syndrome in stroke patients / I. Schlesinger,I. Erikh, M. Nassar, E. Sprecher // Sleep Medicine. – 2015. – Vol. 16, №8. – P. 1006–1010.151. Sequential psychological and pharmacological therapies for comorbid andprimary insomnia: study protocol for a randomized controlled trial /C. M. Morin [et al.]//Trials. – 2016. – Vol. 17, № 1. – P. 118.152. Serrano-Duenas, M.
Chronic dopaminergic drug addiction and pathologicgambling in patients with Parkinson’s disease: presentation of four cases / M. SerranoDuenas // German. J. Psychiatry. – 2002. – Vol. 5, № 2. – P. 62–66.153. Small fiber neuropathy: a common and important clinical disorder /E. Hoitsma [et al.] // J. Neurol. Sci. – 2004.
– Vol. 227, № 1. – P. 119–130.154. Stewart, J. D. Distal small fiber neuropathy: results of tests of sweating and104autonomic cardiovascular reflexes / J. D. Stewart, P. A. Low, R. D. Fealey // MuscleNerve. – 1992. – Vol. 15, № 6. – P. 661–665.155. Stiasny, K. Restless legs syndrome and its treatment by dopamine agonists /K. Stiasny, T. C. Wetter, C. Trenkwalder // Parkinsonism Relat. Disord. – 2000. – Vol. 7,№ 1.
–P. 21–25.156. Study links severe restless legs syndrome to increased risk of stroke[Электронный ресурс]. – American Academy of Sleep Medicine. – 2015. –Режимдоступа:https://www.sciencedaily.com/releases/2015/06/150608120224.htm(датаобращения 06.10.2016).157. Subclinical sensory neuropathy in late–onset restless legs syndrome /M. Polydefkis [et al.] // Neurology. – 2000. – Vol. 55, № 8.
– P. 1115–1121.158. Subjective hypnotic efficacy of trazodone and zolpidem in DSMIII–Rprimary insomnia / J. K. Walsh [et al.] // Psychopharmacol. – 1998. – Vol. 13, № 3. –P. 191–198.159. Successful treatment of the idiopathic restless legs syndrome in arandomized double–blind trial of oxycodone versus placebo / A.
S. Walters [et al.] //Sleep. – 1993. – Vol. 16, № 4. – P. 327–332.160. Support for dopaminergic hypoactivity in restless legs syndrome: a PETstudy on D2-receptor binding / S. Cervenka [et al.] // Brain. – 2006. – Vol. 129. – P. 2017–2028.161.
Suzuki, K. Restless ‘lower back’ in a patient with Parkinson’s disease[Электронныйресурс] / K. Suzuki, M. Miyamoto, T. Miyamoto // Tremor and OtherHyperkineticMovements.–2013.–https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822403/Режим(датадоступа:обращения31.03.2017).162. The dopaminergic neurons of the A11 system in RLS autopsy brains appearnormal / C.
J. Earley [et al.] // Sleep Med. – 2009. – Vol. 10, №10. – P. 1155–1157.163. The effectiveness of treatment with trazodone in patients with primaryinsomnia without and with prior history of hypnotics use / A. Wichniak [et al.] // PolMerkur Lekarski. – 2007. – Vol.
23, №133. – P. 41–46.105164. The London Practice of Physick. London / T. Willis [et al.] – Early Englishbooks, 1685.165. The long-term treatment of restless legs syndrome/Willis-Ekbom disease:evidence-based guidelines and clinical consensus best practice guidance: a report fromthe International Restless Legs Syndrome Study Group / D. Garcia-Borreguero [et al.] //Sleep Med. – 2013.
– Vol. 14, № 7. – P. 675–684.166. The long-term treatment of restless legs syndrome/Willis-Ekbom disease:evidence-based guidelines and clinical consensus best practice guidance: a report fromthe International Restless Legs Syndrome Study Group / D. Garcia-Borreguero [et al.] //Sleep Med. – 2014. – Vol.
15, № 8. – P. 860–873.167. The prevalence and impact of restless legs syndrome on patients with irondeficiency anemia / R. P. Allen [et al.] // Am J Hematol. – 2013. – Vol. 88, № 4. – P. 261–264.168. The prevalence of restless legs syndrome among pregnant women in Japanand the relationship between restless legs syndrome and sleep problems / K. Suzuki [etal.] // Sleep.
– 2003. – Vol. 26, № 6. – P. 673–677.169. The role of opioids in restless legs syndrome: an [11C] diprenorphine PETstudy / S. von Spiczak [et al.] // Brain. – 2005. – Vol. 128, № 4. – P. 906–917.170. Thermal hypoaesthesia differentiates secondary restless legs syndromeassociated with small fibre neuropathy from primary restless legs syndrome /C. G. Bachmann [et al.] // Brain. – 2010. – Vol. 133. – P. 762–770.171. Transcranial ultrasound shows nigral hypoechogenicity in restless legssyndrome / C.
Schmidauer[et al.] // Ann. Neurol. – 2005. – Vol. 58. – P. 630–634.172. Trazodone improves the results of cognitive behaviour therapy of primaryinsomnia in non-depressed patients / L. Zavesicka [et al.] //Neuro Endocrinol Lett. – 2008.– Vol. 29, № 6. – P. 895–901.173. Treatment of restless legs syndrome: An evidence–based review andimplications for clinical practice / C. Trenkwalder [et al.] // Mov. Disord. – 2008. –Vol. 23, № 16.
– P. 2267–2302.174. Treatment Options in Intractable Restless Legs Syndrome/Willis-Ekbom106Disease (RLS/WED) / F. Rinaldi [et al.] // Curr. Treat. Options Neurol. – 2016. – Vol. 8,№ 2. – P. 7.175. Trenkwalder, C. The restless legs syndrome / C. Trenkwalder, W. Paulus, A.S. Walters // Lancet Neurol. – 2005. – Vol. 4, № 8. – P. 465–475.176. Trzepacz, P. T. Response to opioids in three patients with restless legssyndrome / P. T. Trzepacz, E. J.
Violette, M. J. Satiea // Am J Psychiatry. – 1984. –Vol. 141. – P. 993–995.177. Ulfberg, J. Prevalence of restless legs syndrome among men aged 18 to 64years: an association with somatic disease and neuropsychiatric symptoms / J. Ulfberg,B. Nystrom, N. Carter // Mov. Disord. – 2001. – Vol. 16, № 6. – P. 1159–1163.178.
Umehara, H. Restless legs syndrome with chest and back restlessness as theinitial symptom / H. Umehara, S. Sumitani, T. Ohmori // Psychiatry and ClinicalNeurosciences. – 2010. – Vol. 64, № 2. – P. 211.179. Validation of the International Restless Legs Syndrome Study Group ratingscale for restless legs syndrome / Walters A.
S. [et al.] // Sleep Med. – 2003. – Vol. 4, №2. – P. 121– 132.180. Voon, V. Repetition, repetition, and repetition: Compulsive and pundingbehaviors in Parkinson’s disease / V. Voon // Mov. Disord. – 2004. – Vol. 19, № 4. –P. 367–370.181. Walker, S. Sleep complaints are common in a dialysis unit / S. Walker,A. Fine, M. H. Kryger // Am. J. Kidney Dis. – 1995.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
